Neonatal Fc Receptor Blocker [EPC] - N0000194004

Pharmacologic Class Information

Pharmacologic Code N0000194004
Pharmacologic Name Neonatal Fc Receptor Blocker
Pharmacologic Uses
  • neonatal Fc receptor blocker
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Neonatal Fc Receptor Blocker

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Neonatal Fc Receptor Blocker [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
73475-3041Vyvgart Non-Proprietary Name: Efgartigimod AlfaInjectionIntravenousArgenx UsACTIVE
73475-3102Vyvgart Hytrulo Non-Proprietary Name: Efgartigimod Alfa And Hyaluronidase (human Recombinant)Injection, SolutionSubcutaneousArgenx UsACTIVE